Vivozon Holdings Files Additional Share Pledge to Maintain Collateral Ratios for Vivozon Pharmaceutical, No Change in Ownership
Vivozon Holdings reported on July 10 that it has completed an additional pledge of its shares in Vivozon Pharmaceutical to maintain collateral coverage ratios for existing loans.
While the total shares held of 19,787,259 and stake of 31.72% remain unchanged, the number of shares under major contracts pledges and exchangeable bonds increased from 10,513,471 to 12,544,758, raising the ratio from 16.85% to 20.11%.
The extra pledging was triggered by a decline in the stock price requiring higher collateral. Notably, Vivozon Holdings took out a 6.5 billion won loan from SangSangin Savings Bank at a high 11% interest rate, adding financial burden.
For minority shareholders, there is no direct dilution from new share issuance, but the increased pledging signals financial stress on the largest shareholder, heightening uncertainty.
[AI Summary]This additional pledge by Vivozon Holdings is a defensive financial maneuver with no change in ownership, reflecting pressure from falling share prices on collateral maintenance. Although high-interest debt costs exist, the current impact on control and equity structure is neutral.